CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 8-K Event Results of operations · Regulation FD disclosure · Other events
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Material agreement
- S-3ASR Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes Chief Scientific Officer gave up 12,385 shares (to pay taxes)
- 4 Option exercise Director acquired 11,580 shares (option exercise)
- 4 Option exercise Director acquired 11,580 shares (option exercise)
- 4 Option exercise Director acquired 11,580 shares (option exercise)
- 4 Option exercise Director acquired 11,580 shares (option exercise)
- 4 Option exercise Director acquired 11,580 shares (option exercise)
- 4 Option exercise Director acquired 11,580 shares (option exercise)
- 8-K Event Shareholder vote results
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
Page 1 of 44 · 872 filings